Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP750070.RAugZIQOnKI-GrESFrC3-G5funZ0vM4B5qQKxb4zZNOL0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP750070.RAugZIQOnKI-GrESFrC3-G5funZ0vM4B5qQKxb4zZNOL0130_assertion type Assertion NP750070.RAugZIQOnKI-GrESFrC3-G5funZ0vM4B5qQKxb4zZNOL0130_head.
- NP750070.RAugZIQOnKI-GrESFrC3-G5funZ0vM4B5qQKxb4zZNOL0130_assertion description "[Their levels fell further with increasing tumour's stage and were higher in tumours from patients who remained disease free compared with those who developed local recurrence or distant metastasis or died from breast cancer.TRF2 showed a trend similar to that of TANK2 and POT1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP750070.RAugZIQOnKI-GrESFrC3-G5funZ0vM4B5qQKxb4zZNOL0130_provenance.
- NP750070.RAugZIQOnKI-GrESFrC3-G5funZ0vM4B5qQKxb4zZNOL0130_assertion evidence source_evidence_literature NP750070.RAugZIQOnKI-GrESFrC3-G5funZ0vM4B5qQKxb4zZNOL0130_provenance.
- NP750070.RAugZIQOnKI-GrESFrC3-G5funZ0vM4B5qQKxb4zZNOL0130_assertion SIO_000772 17616810 NP750070.RAugZIQOnKI-GrESFrC3-G5funZ0vM4B5qQKxb4zZNOL0130_provenance.
- NP750070.RAugZIQOnKI-GrESFrC3-G5funZ0vM4B5qQKxb4zZNOL0130_assertion wasDerivedFrom befree-20140225 NP750070.RAugZIQOnKI-GrESFrC3-G5funZ0vM4B5qQKxb4zZNOL0130_provenance.
- NP750070.RAugZIQOnKI-GrESFrC3-G5funZ0vM4B5qQKxb4zZNOL0130_assertion wasGeneratedBy ECO_0000203 NP750070.RAugZIQOnKI-GrESFrC3-G5funZ0vM4B5qQKxb4zZNOL0130_provenance.